CAS: 2068119-11-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | S18-000003 REF: 54-BUP09206CAS: 2068119-11-7 | 99.8% | 500.00 €~1,788.00 € | Thu 17 Apr 25 |
 | S18-000003 REF: TM-T16832CAS: 2068119-11-7 | 99.24% - 99.31% | 57.00 €~1,320.00 € | Wed 23 Apr 25 |
 | S18-000003 REF: 3D-THD11911CAS: 2068119-11-7 | Min. 95% | To inquire | Wed 28 May 25 |
Ref: 54-BUP09206
| 25mg | 500.00 € | ||
| 50mg | 702.00 € | ||
| 100mg | 971.00 € | ||
| 500mg | 1,788.00 € |
Estimated delivery in United States, on Thursday 17 Apr 2025
S18-000003
CAS:2068119-11-7
S18-000003: Oral retinoic acid receptor gamma-t inhibitor, IC50 29 nM, reduces IL-17 production.
Formula:
C26H25F3N2O4S
Purity:
99.24% - 99.31%
Color and Shape:
Solid
Molecular weight:
518.55
Ref: TM-T16832
| 1mg | 57.00 € | ||
| 5mg | 125.00 € | ||
| 10mg | 188.00 € | ||
| 25mg | 335.00 € | ||
| 50mg | 470.00 € | ||
| 100mg | 662.00 € | ||
| 500mg | 1,320.00 € | ||
| 1mL*10mM (DMSO) | 142.00 € |
Estimated delivery in United States, on Wednesday 23 Apr 2025
S18-000003
CAS:2068119-11-7
Please enquire for more information about S18-000003 including the price, delivery time and more detailed …
Formula:
C26H25F3N2O4S
Purity:
Min. 95%
Molecular weight:
518.5 g/mol
Ref: 3D-THD11911
| 5mg | 1,033.00 € | ||
| 10mg | 1,348.00 € | ||
| 25mg | 2,284.00 € | ||
| 50mg | 3,045.00 € | ||
| 100mg | 4,441.00 € |
Estimated delivery in United States, on Wednesday 28 May 2025
